Chilton Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chilton Capital Management's LLY Position: Q3 2026 in Review
Chilton Capital Management increased its Eli Lilly (LLY) stake by 0.76% in Q3 2026, buying an estimated $621K and bringing the position to 69,812 shares worth $80.8M. The position accounts for 2.54% of the portfolio, ranked #9.
Chilton Capital Management first reported a position in LLY in Q2 2013 and has held it in 25 quarters since. The position peaked at $83.1M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Chilton Capital Management held 69,812 shares of Eli Lilly worth $80.8M as of Q3 2026.
- Chilton Capital Management bought 526 Eli Lilly shares in Q3 2026, an estimated $621K.
- Eli Lilly made up 2.54% of Chilton Capital Management's portfolio in Q3 2026, its #9 holding.
- Chilton Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 25 quarters since.
- Chilton Capital Management's Eli Lilly position peaked at $83.1M in Q2 2026.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Chilton Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.